Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to investigate the safety, tolerability and effectiveness of
CAST as a treatment for diabetic neuropathy. The primary outcome measure will be Total
Neuropathic Symptom Score. Secondary outcomes will be neurological disability score, nerve
conduction measurements and quantitative sensory testing. Statistical analyses will compare
changes from baseline for CAST- and placebo-treated groups at both time points, compare
effects of CAST at 6 and 12 months and, if numbers permit, compare doses.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)